Cuprate(2-), [4-[4,5-dihydro-4-[2-[4-[[3-[2-[4,5-dihydro-3-methyl-1-(2-methyl-4-sulfophenyl)-5-(oxo-kappaO)-1H-pyrazol-4-yl]diazenyl-kappaN1]-2-hydroxyphenyl]methyl]phenyl]diazenyl]-3-methyl-5-oxo-1H-pyrazol-1-yl]-3-methylbenzenesulfonato(4-)]-, sodium (1:2)

식별자 및 물리적 특성

CAS No.	73324-03-5
분자식	C35H28CuN8O9S2.2Na
평균 분자량	878.3 g/mol
단동위원소 질량	877.051203 g/mol
SMILES	CC1=NN(c2ccc(S(=O)(=O)[O-])cc2C)C(=O)C1N=Nc1ccc(Cc2cccc(N=Nc3c(C)nn(-c4ccc(S(=O)(=O)[O-])cc4C)c3[O-])c2[O-])cc1.[Cu+2].[Na+].[Na+]
InChIKey	PQULSEJFZXKQDN-UHFFFAOYSA-J
PubChem CID	175463

규제 정보	Chemical: Cuprate(2-), [4-[4,5-dihydro-4-[[4-[[4-[[4,5-dihydro-3-methyl-1-(2-methyl-5-sulfophenyl)-5-oxo-1H-pyrazol-4-yl]azo]-3-hydroxyphenyl]methyl]phenyl]azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]-5-methylbenzenesulfonato(4-)]-, disodium
기타 안전 정보	IMAP assessments - Cuprate(2-), [4-[4,5-dihydro-4-[[4-[[4-[[4,5-dihydro-3-methyl-1-(2-methyl-5-sulfophenyl)-5-oxo-1H-pyrazol-4-yl]azo]-3-hydroxyphenyl]methyl]phenyl]azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]-5-methylbenzenesulfonato(4-)]-, disodium: Human health tier I assessment